Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 55Other hematologic neoplasm 15Lymphoid 12Plasma cell 11Breast 7Other neoplasm 5Myeloid 5Thoracic 4Gastrointestinal 4Head & Neck 3Dermatologic 3Gynecologic 2Genitourinary 2Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Anemia 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Epoetin Alfa × Head & Neck × Clear all
NCT00004917 2020-10-22

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anemia, Head and Neck Neoplasms

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed
1 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00017277 2012-09-24

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡